Aptus Pharma Ltd IPO

The company does not have its own manufacturing facility for pharmaceutical products and the company have to relies on third parties for contract manufacturing of the products sold by the Company.

The company are required to obtain, renew or maintain certain material statutory and regulatory permits and approvals required to operate its business, and if the company fail to does so in a timely manner or at all, its may be unable to operate the company business and its results of operations may be adversely affected.

The company derive a significant part of the company revenue from few customers. If one or more of such customers choose not to source their requirements from the company or to terminate its contracts or purchase orders, the company business, cash flows, financial condition and results of operations may be adversely affected.

If the company are unable to protect its intellectual property rights, the company business, results of operations and financial condition may be adversely affected. Further, if its products were found to be infringing on the intellectual property rights of a third-party, the company could be required to cease selling the infringing products, causing the company to lose future sales revenue from such products and face substantial liabilities for infringement of intellectual property rights.

The Company may be exposed to product liability and other claims arising from defective medicines manufactured by third-party Contract Manufacturers, despite having manufacturing agreements in place, as indemnity terms are not pre-determined.

The company are highly dependent on the medical practitioners including general physicians, paediatricians, gynaecologists, cardiologists, endocrinologists, neurologists, and others. Any disruption in such understanding may adversely impact its business operations.

The company business is working capital intensive. If its are unable to borrow to meet the company working capital requirements, it may materially and adversely affect its business and results of operations.

The company have had negative cash flows from operating activities in the last three Fiscal years and may continue to have negative cash flows in the future which could have an impact on its business and operations.

The Company does not have intellectual property rights over its corporate logo. In absence of the company Registered Logo or Trademark there are chances of getting damage to its business prospects, reputation and goodwill and misuse of the company logo.

There have been certain delays in filing of GST, PF/ESIC returns of the company. Consequently, its may be subject to adverse regulatory actions and penalties for any past or future non-compliance and the company business, financial condition and reputation may be adversely affected.